![]() OxThera OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate. | |||
Founding Date | Founding Date N/A | Founding Date 2020 | Founding Date 1986 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Stockholm, SE HQ Knoxville, US | Locations Austin, US HQ Ames, US | Locations Crumlin, GB HQ Freiburg Im Breisgau, DE Cape Town, ZA Edinburgh, GB Porton Down, GB Sittingbourne, GB see more |
Employees | Employees 7 | Employees 333% increase | Employees 3491% increase |
Financial | |||
Revenue (est.) | Revenue (est.) kr11m (FY, 2015) | Revenue (est.) $2.1m (FY, 2023) | Revenue (est.) £55.5m (FY, 2020) |
Net income | Net income (kr37.8m) (FY, 2015) | Net income ($34m) (FY, 2023) | Net income (£9.9m) (FY, 2020) |

Lumos Pharma is a biopharmaceutical company developing therapeutics for rare diseases.
View companyBBI Solutions is a company that develops and manufactures immuno-diagnostics reagents.
View company